LitCovid-sample-Enju  

PMC:7205724 / 15948-16625 JSONTXT 16 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T22068 0-7 CD denotes 4.1.3.2
T96302 9-17 NNP denotes Rational
T46108 17-18 -COLON- denotes :
T36509 19-24 NN denotes Serum
T11172 25-29 IN denotes from
T88528 30-42 JJ denotes convalescent
T76648 43-47 NN denotes SARS
T87601 48-56 NNS denotes patients
T31307 57-59 VBZ denotes is
T95865 60-64 JJ denotes able
T8130 65-67 TO denotes to
T87404 68-78 VB denotes neutralize
T83073 79-88 NN denotes SARS-CoV2
T56983 89-100 RB denotes efficiently
T85498 101-110 NN denotes Antiserum
T54727 111-115 WDT denotes that
T58025 116-124 VBZ denotes contains
T31794 125-135 NNS denotes antibodies
T72017 136-143 IN denotes against
T23410 144-149 JJ denotes human
T51011 150-154 NN denotes ACE2
T21969 155-160 MD denotes could
T10956 161-167 VB denotes hinder
T54161 168-171 DT denotes the
T78002 172-177 NN denotes entry
T48418 178-180 IN denotes of
T60794 181-185 CC denotes both
T68393 186-192 NN denotes SARS-S
T60207 193-196 CC denotes and
T37089 197-205 NN denotes SARS-2-S
T99631 206-217 NNS denotes pseudotypes
T70219 218-223 IN denotes while
T16218 224-227 RB denotes not
T76542 228-236 VBN denotes affected
T34278 237-240 DT denotes the
T2430 241-246 NN denotes entry
T98023 247-249 IN denotes of
T1819 250-255 NN denotes VSV-G
T13278 256-259 CC denotes and
T45315 260-266 NN denotes MERS-S
T32075 267-278 NNS denotes pseudotypes
T4602 280-282 PRP denotes It
T44962 283-291 VBZ denotes supports
T87111 292-295 DT denotes the
T50457 296-302 NN denotes notion
T41218 303-307 IN denotes that
T5721 308-314 NN denotes SARS-S
T21671 315-318 CC denotes and
T31105 319-327 NN denotes SARS-2-S
T49586 328-335 VBP denotes utilize
T31036 336-339 DT denotes the
T80074 340-344 JJ denotes same
T64684 345-352 JJ denotes primary
T36069 353-358 NN denotes entry
T27754 359-367 NN denotes receptor
T79207 367-368 -COMMA- denotes ,
T14629 369-373 FW denotes i.e.
T9665 373-374 -COMMA- denotes ,
T94116 375-379 NN denotes ACE2
T13974 379-380 -COMMA- denotes ,
T82487 381-386 WDT denotes which
T59931 387-389 VBZ denotes is
T21885 390-399 JJ denotes different
T2868 400-404 IN denotes from
T75369 405-408 DT denotes the
T44853 409-416 JJ denotes primary
T60868 417-426 NNS denotes receptors
T62157 427-432 NN denotes VSV-G
T53624 433-436 CC denotes and
T83630 437-443 NN denotes MERS-S
T67890 444-450 NN denotes engage
T48926 451-454 IN denotes for
T62543 455-459 NN denotes cell
T63733 460-465 NN denotes entry
T54619 466-470 WDT denotes that
T50860 471-473 VBZ denotes is
T99869 474-478 NN denotes LDLR
T6180 479-482 CC denotes and
T74051 483-487 NN denotes DPP4
T7846 487-488 -COMMA- denotes ,
T3162 489-501 RB denotes respectively
T66548 503-507 NN denotes Sera
T80239 508-512 IN denotes from
T68000 513-518 CD denotes three
T48403 519-531 JJ denotes convalescent
T51594 532-536 NN denotes SARS
T70519 537-545 NNS denotes patients
T59987 546-553 VBD denotes reduced
T66409 554-557 DT denotes the
T72671 558-564 JJ denotes SARS-S
T28601 565-570 NN denotes entry
T35673 571-574 CC denotes and
T3889 574-575 -COMMA- denotes ,
T61995 576-578 TO denotes to
T2565 579-580 VB denotes e
T43059 581-587 JJR denotes lesser
T78742 588-594 NN denotes degree
T89272 594-595 -COMMA- denotes ,
T22714 596-599 DT denotes the
T31064 600-608 NN denotes SARS-2-S
T32416 609-614 NN denotes entry
T56518 616-619 DT denotes The
T9724 620-627 NN denotes patient
T98703 628-633 NN denotes serum
T27055 634-640 NN denotes effect
T61320 641-644 VBD denotes was
T14991 645-647 IN denotes in
T7555 648-649 DT denotes a
T3238 650-664 JJ denotes dose-dependent
T1832 665-671 NN denotes manner
T4817 672-673 -LRB- denotes [
T18384 673-675 CD denotes 16
T62562 675-676 -RRB- denotes ]
R12626 T87404 T95865 arg2Of neutralize,able
R12822 T62157 T60868 arg1Of VSV-G,receptors
R12975 T85498 T10956 arg1Of Antiserum,hinder
R13076 T87601 T88528 arg1Of patients,convalescent
R13635 T27754 T31036 arg1Of receptor,the
R15400 T2430 T34278 arg1Of entry,the
R17700 T50860 T3162 arg1Of is,respectively
R19016 T62562 T4817 arg3Of ],[
R22357 T10956 T70219 arg1Of hinder,while
R23798 T1819 T13278 arg1Of VSV-G,and
R26875 T27055 T9724 arg1Of effect,patient
R26919 T28601 T59987 arg2Of entry,reduced
R26981 T31105 T21671 arg2Of SARS-2-S,and
R27618 T32075 T98023 arg2Of pseudotypes,of
R27782 T5721 T21671 arg1Of SARS-S,and
R28408 T50457 T21885 arg1Of notion,different
R29591 T53624 T2868 arg2Of and,from
R31390 T18384 T4817 arg2Of 16,[
R32051 T70519 T48403 arg1Of patients,convalescent
R32091 T45315 T13278 arg2Of MERS-S,and
R32288 T32416 T22714 arg1Of entry,the
R33164 T28601 T66409 arg1Of entry,the
R33669 T85498 T54727 arg1Of Antiserum,that
R33918 T78742 T43059 arg1Of degree,lesser
R35338 T21671 T49586 arg1Of and,utilize
R36526 T21885 T59931 arg2Of different,is
R37669 T50457 T44962 arg2Of notion,supports
R38725 T50457 T59931 arg1Of notion,is
R38960 T78742 T2565 arg2Of degree,e
R39396 T87601 T11172 arg2Of patients,from
R40823 T36509 T87404 arg1Of Serum,neutralize
R42281 T76542 T70219 arg2Of affected,while
R42628 T99631 T37089 arg1Of pseudotypes,SARS-2-S
R45507 T59987 T61995 modOf reduced,to
R46087 T61320 T4817 arg1Of was,[
R47396 T4602 T44962 arg1Of It,supports
R48104 T31794 T72017 arg1Of antibodies,against
R48533 T76542 T16218 arg1Of affected,not
R49023 T53624 T75369 arg1Of and,the
R49876 T50457 T13974 arg1Of notion,","
R5011 T32075 T45315 arg1Of pseudotypes,MERS-S
R50111 T36509 T11172 arg1Of Serum,from
R50669 T66548 T59987 arg1Of Sera,reduced
R50831 T96302 T22068 arg1Of Rational,4.1.3.2
R51417 T67890 T83630 arg1Of engage,MERS-S
R51750 T27055 T98703 arg1Of effect,serum
R52514 T63733 T48926 arg2Of entry,for
R52768 T27754 T79207 arg1Of receptor,","
R53724 T27754 T36069 arg1Of receptor,entry
R55546 T49586 T41218 arg1Of utilize,that
R56160 T70519 T51594 arg1Of patients,SARS
R56953 T87404 T56983 arg1Of neutralize,efficiently
R57057 T27055 T14991 arg1Of effect,in
R57062 T36509 T31307 arg1Of Serum,is
R57112 T59987 T35673 arg1Of reduced,and
R58115 T74051 T6180 arg2Of DPP4,and
R5834 T63733 T62543 arg1Of entry,cell
R58389 T63733 T50860 arg1Of entry,is
R58480 T31794 T58025 arg2Of antibodies,contains
R58905 T37089 T60207 arg2Of SARS-2-S,and
R59126 T27754 T80074 arg1Of receptor,same
R59565 T1832 T7555 arg1Of manner,a
R60685 T32416 T89272 arg2Of entry,","
R60809 T85498 T58025 arg1Of Antiserum,contains
R60896 T32416 T31064 arg1Of entry,SARS-2-S
R61217 T53624 T48926 arg1Of and,for
R63232 T10956 T21969 arg2Of hinder,could
R64065 T99631 T60794 arg1Of pseudotypes,both
R64835 T67890 T53624 arg2Of engage,and
R65884 T32075 T1819 arg1Of pseudotypes,VSV-G
R66611 T70519 T80239 arg2Of patients,from
R67933 T1832 T14991 arg2Of manner,in
R68217 T83073 T87404 arg2Of SARS-CoV2,neutralize
R68489 T27055 T56518 arg1Of effect,The
R69132 T70519 T68000 arg1Of patients,three
R7189 T1832 T3238 arg1Of manner,dose-dependent
R75542 T59987 T3889 arg1Of reduced,","
R75777 T51011 T23410 arg1Of ACE2,human
R75797 T95865 T31307 arg2Of able,is
R76622 T36509 T95865 arg1Of Serum,able
R77219 T63733 T54619 arg1Of entry,that
R77915 T87404 T8130 arg1Of neutralize,to
R79160 T50860 T7846 arg1Of is,","
R79405 T2430 T76542 arg3Of entry,affected
R80345 T27754 T14629 arg1Of receptor,i.e.
R80403 T78002 T54161 arg1Of entry,the
R80889 T85498 T76542 arg2Of Antiserum,affected
R81402 T27055 T61320 arg1Of effect,was
R83525 T51011 T72017 arg2Of ACE2,against
R83550 T49586 T50457 arg2Of utilize,notion
R84898 T66548 T80239 arg1Of Sera,from
R8551 T99869 T6180 arg1Of LDLR,and
R85999 T14991 T61320 arg2Of in,was
R87251 T62157 T53624 arg1Of VSV-G,and
R89421 T78002 T48418 arg1Of entry,of
R90018 T94116 T9665 arg2Of ACE2,","
R90486 T87601 T76648 arg1Of patients,SARS
R90719 T21885 T2868 arg1Of different,from
R91188 T78002 T10956 arg2Of entry,hinder
R92127 T62157 T44853 arg1Of VSV-G,primary
R9222 T50457 T82487 arg1Of notion,which
R92327 T2565 T61995 arg1Of e,to
R92599 T50457 T87111 arg1Of notion,the
R92749 T99631 T68393 arg1Of pseudotypes,SARS-S
R93157 T2430 T98023 arg1Of entry,of
R9363 T85498 T21969 arg1Of Antiserum,could
R93750 T27754 T64684 arg1Of receptor,primary
R95761 T78742 T89272 arg1Of degree,","
R96844 T28601 T72671 arg1Of entry,SARS-S
R9702 T27754 T9665 arg1Of receptor,","
R97711 T96302 T46108 arg1Of Rational,:
R97853 T6180 T50860 arg2Of and,is
R99271 T27754 T49586 arg2Of receptor,utilize
R99421 T68393 T60207 arg1Of SARS-S,and
R99899 T99631 T48418 arg2Of pseudotypes,of